
Amdocs Limited (NASDAQ:DOX – Free Report) – Investment analysts at Zacks Research reduced their FY2026 EPS estimates for shares of Amdocs in a note issued to investors on Wednesday, August 26th. Zacks Research analyst Team now expects that the technology company will post earnings of $6.57 per share for the year, down from their previous estimate of $6.60. The consensus estimate for Amdocs’ current full-year earnings is $6.56 per share. Zacks Research also issued estimates for Amdocs’ Q4 2026 earnings at $1.78 EPS, Q1 2027 earnings at $1.71 EPS, Q2 2027 earnings at $1.71 EPS, Q3 2027 earnings at $1.76 EPS, FY2027 earnings at $6.99 EPS, Q2 2028 earnings at $1.93 EPS, Q3 2028 earnings at $1.97 EPS and FY2028 earnings at $7.79 EPS.
Amdocs (NASDAQ:DOX – Get Free Report) last issued its earnings results on Thursday, August 6th. The technology company reported $1.84 EPS for the quarter, hitting the consensus estimate of $1.84. Amdocs had a return on equity of 20.28% and a net margin of 9.75%.The business had revenue of $1.17 billion during the quarter, compared to analysts’ expectations of $1.18 billion. During the same quarter last year, the firm posted $1.72 earnings per share. Amdocs’s revenue was up 2.7% compared to the same quarter last year.
Get Our Latest Stock Analysis on Amdocs
Amdocs Stock Down 0.7%
Shares of Amdocs stock opened at $62.60 on Monday. The stock has a 50-day moving average price of $55.53 and a 200 day moving average price of $61.01. The company has a market cap of $6.76 billion, a P/E ratio of 14.90, a P/E/G ratio of 1.10 and a beta of 0.42. The company has a current ratio of 0.94, a quick ratio of 0.94 and a debt-to-equity ratio of 0.23. Amdocs has a 1 year low of $49.74 and a 1 year high of $86.14.
Institutional Trading of Amdocs
Large investors have recently added to or reduced their stakes in the business. Pzena Investment Management LLC increased its stake in shares of Amdocs by 82.6% during the 4th quarter. Pzena Investment Management LLC now owns 12,037,015 shares of the technology company’s stock worth $969,100,000 after purchasing an additional 5,443,766 shares during the last quarter. Alyeska Investment Group L.P. boosted its holdings in Amdocs by 155.1% in the fourth quarter. Alyeska Investment Group L.P. now owns 2,110,393 shares of the technology company’s stock worth $169,908,000 after purchasing an additional 1,283,231 shares in the last quarter. Dimensional Fund Advisors LP boosted its holdings in Amdocs by 19.7% in the first quarter. Dimensional Fund Advisors LP now owns 3,463,797 shares of the technology company’s stock worth $226,045,000 after purchasing an additional 571,036 shares in the last quarter. Squarepoint Ops LLC increased its position in Amdocs by 469.4% during the fourth quarter. Squarepoint Ops LLC now owns 543,875 shares of the technology company’s stock worth $43,787,000 after buying an additional 448,358 shares during the last quarter. Finally, Voloridge Investment Management LLC increased its position in Amdocs by 501.1% during the fourth quarter. Voloridge Investment Management LLC now owns 520,494 shares of the technology company’s stock worth $41,905,000 after buying an additional 433,907 shares during the last quarter. 92.02% of the stock is owned by institutional investors.
Amdocs Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be paid a $0.569 dividend. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $2.28 annualized dividend and a dividend yield of 3.6%. Amdocs’s payout ratio is presently 54.29%.
About Amdocs
Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.
Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.
Further Reading
- Five stocks we like better than Amdocs
- Dutch Bros Sell-Off Creates a Growth Opportunity
- NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat
- Is Abercrombie & Fitch’s Hot Streak Just Getting Started?
- Medtronic’s Stars Are Aligning for a Price Recovery
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.
